Alice Lione – Pagina 28 – AMD

Alice Lione

Febbraio 3, 2025 Alice Lione

Global, regional, and national burdens of type 1 and type 2 diabetes mellitus in adolescents from 1990 to 2021, with forecasts to 2030: a systematic analysis of the global burden of disease study 2021

Chen X, Zhang L, Chen W
BMC Med. 2025;23(1):48.

Leggi

Febbraio 3, 2025 Alice Lione

Islet autoantibody screening throughout Australia using in-home blood spot sampling: 2-year outcomes of Type1Screen

Wentworth JM, Sing ABE, Naselli G, et al.
Diabetes Care. 2025:dc242443.

Leggi

Febbraio 3, 2025 Alice Lione

Impact of time in tight range on all-cause and cardiovascular mortality in type 2 diabetes: a prospective cohort study

Cai J, Liu J, Lu J, et al.
Diabetes Obes Metab. Pub. online 27 Jan 2025.

Leggi

Febbraio 3, 2025 Alice Lione

Decision-making behavior of blood glucose management and its influencing factors in pregnant women with gestational diabetes mellitus

Xu S, Wang J, Wang Y, et al.
BMC Pregnancy Childbirth. 2025;25(1):83.

Leggi

Gennaio 29, 2025 Alice Lione

I AMD Family – Riflessioni sull’indirizzo societario, sul posizionamento attuale e futuro di AMD | 5 febbraio 2025 – Roma

Leggi

Gennaio 30, 2025 Alice Lione

AIFA: ll CdA AIFA approva la rimborsabilità, in tutte le Regioni, del farmaco BAQSIMI (glucagone spray nasale) e di due farmaci per il trattamento del diabete mellito (MOUNJARO e AWIQLI)

29/01/2025

Leggi

Gennaio 30, 2025 Alice Lione

Long-term improvements in glycemia and user-reported outcomes associated with open-source automated insulin delivery systems in adults with type 1 diabetes in the United Kingdom: a real-world observational study

Liarakos AL, Crabtree TSJ, Hussain S, et al.
Diabetes Technol Ther. Pub. online 27 Jan 2025.

Leggi

Gennaio 30, 2025 Alice Lione

Diabetes risk after treatment for childhood and young adult cancer

Cromie KJ, Murray RD, Ajjan RA, et al.
Diabetes Care. 2025:dc242171.

Leggi

Gennaio 30, 2025 Alice Lione

Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial

Liu Y, Chen Y, Ma J, et al.
BMJ. 2025;388:e081820.

Leggi

Gennaio 30, 2025 Alice Lione

Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes

Amendolara R, Zampetti S, Siena A, et al.
Diabetes Res Clin Pract. 2025:112006.

Leggi